Evidera
Michael Stokes is a seasoned research scientist with extensive experience in study design, statistical analysis, and project management, currently employed at Evidera since July 2006. Previous positions include serving as a senior analyst at i3 Innovus, where responsibilities included analyzing large insurance claims databases and mentoring colleagues in SAS, and a student intern at the Centers for Disease Control and Prevention, focusing on data retrieval and correction. Michael holds a Master of Public Health in Epidemiology from Emory University and a Bachelor of Science in Biology from Binghamton University.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.